Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies

Oncotarget. 2019 Mar 1;10(18):1662-1663. doi: 10.18632/oncotarget.26718.

Authors

Laura Hüser¹, Peter Altevogt¹, Jochen Utikal¹

Affiliation

¹ Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.

No abstract available

Keywords: BRAF; Sox2; melanoma; resistance; targeted therapy.

Publication types

Editorial